QJQ GER Week ended 07 Aug 2026

Weekly Investor Report

ISS A/S · Industrials · Specialty Business Services

Open interactive chart View report data
Latest close 37.02 EUR
-3.5% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is - below the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned -3.5%, after a -1.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100.

Setup score 45 out of 100
Latest Close 37.02 EUR 7 Aug 2026
1W Return -3.5% latest completed week
4W Return -1.3% short-term follow-through
12W Return 14.0% quarterly tape
Trend Breadth 0.0% 0 of 28 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • 6 reversal markers appear in the recent smart-money tape.
What to watch next
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -3.5% Latest completed week; four-week move -1.3%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 50/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is - below the Trend Line and sits at 81.4% of its 52-week range. The latest completed week returned -3.5%, after a -1.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4212-week average 0.33

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.42Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers

No recent accumulation markers. 6 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.3% over four weeks, 14.0% over 12 weeks, and - over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-3.5%
4W-1.3%
12W14.0%
26W22.2%
52W-
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.00Latest activity-pressure read.
Pressure change-Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Dec 2025 Field coverage 85% Model confidence 68%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength98/100Blend of value, momentum, and quality. Underlying universe rank 3; rank 1 is best.
Value100/100Relative valuation strength. Underlying universe rank 1; rank 1 is best.
Quality92/100Profitability and accounting quality. Underlying universe rank 9; rank 1 is best.
Momentum45/100Medium-term price momentum. Underlying universe rank 56; rank 1 is best.
Growth41/100Revenue and earnings growth. Underlying universe rank 60; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
2.2x
Price divided by trailing earnings.
Price / sales
0.1x
Market value relative to trailing revenue.
EV / EBITDA
3.5x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
16.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
91.5%
Gross profit retained from each unit of revenue.
Operating margin
4.8%
Operating profit retained from revenue.
Free-cash-flow margin
3.9%
Free cash flow generated from revenue.
Return on invested capital
13.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.1%
Latest one-year revenue growth.
EPS growth
10.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
7.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.2%
Cash dividends relative to market value.
Buyback yield
48.7%
Net share repurchases relative to market value.
Shareholder yield
49.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 3 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-6.5%Distance below the 52-week high.
13-week volatility3.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 269 weeks finished lower.
Best week+10.5%Week of 17 Apr.
Worst week-7.8%Week of 27 Feb.
Latest week-3.5%Week of 7 Aug.

Shape of recent returns

Strong gains5
Modest gains7
Flat weeks5
Modest losses7
Sharp losses2
Recent vol3.7%13-week weekly-return volatility.
Base vol3.9%52-week weekly-return volatility.
Up/down split13/9Count of positive and negative weeks in the 52-week window.
Average skew4.1% / -2.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis8/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.42; 6 reversal markers Factors84/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 1; Small Cap Core rank 1 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 3 relevant articles.

ISS A/S (QJQ) Q2 2025 Earnings Report - Results, Call & Slides Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202637.02 EUR-3.5%-32.64 EUR0.00-888Off
31 Jul 202638.38 EUR-1.1%-32.47 EUR0.00-948Off
24 Jul 202638.80 EUR0.0%-32.25 EUR0.00-602Off
17 Jul 202638.80 EUR3.4%-31.98 EUR0.00-233Off
10 Jul 202637.52 EUR-1.7%-31.70 EUR0.00-232Off
3 Jul 202638.18 EUR5.4%-31.45 EUR0.00-2Off
26 Jun 202636.24 EUR2.7%-31.14 EUR0.00-0Off
19 Jun 202635.28 EUR-0.2%-30.90 EUR0.00-0Off
12 Jun 202635.34 EUR5.0%-30.68 EUR0.00-0Off
5 Jun 202633.66 EUR-4.3%-30.43 EUR0.00-0Off
29 May 202635.16 EUR-0.7%-30.26 EUR0.00-2.2KOff
22 May 202635.42 EUR9.1%-29.97 EUR0.00-3.0KOff
15 May 202632.46 EUR0.0%-29.63 EUR0.00-0Off
8 May 202632.46 EUR0.0%-29.44 EUR0.00-0Off
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context